(Q46860931)

English

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

type 2 diabetes

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

J Rosenstock

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

B J Goldstein

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

A I Vinik

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

M Colleen O'neill

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

L E Porter

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

M A Heise

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

B Kravitz

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

R G Dirani

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

M I Freed

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

RESULT Study Group

10

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

publication date

1 January 2006

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

49-57

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

Redefining the clinical management of type 2 diabetes: matching therapy to pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00541.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00541.X

21 January 2018

Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00541.X

21 January 2018

Fatty acids, lipotoxicity and insulin secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2005.00541.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2005.00541.X

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16367882

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46860931&oldid=2135176956"